Invesaro

Stocks Health care LNSR

NASDAQ · Health care

LENSAR, Inc. (LNSR)

LENSAR, Inc. brought in $60.3M of revenue over the twelve months to June 30, 2026, up 3.3% from a year earlier. Net income was $34.7M, a net margin of 57.6%. In fiscal 2025 capital spending exceeded operating cash flow by $14.9M. At June 30, 2026 it held $13.6M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.

Revenue (last 12 months)
$60.3M
+3.3% year on year
Net margin
57.6%

What LENSAR, Inc. does

LENSAR, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker LNSR.

Revenue and profit by year

Revenue
FY20: $30.5M $30.5M FY20FY20: $26.4M $26.4M FY20FY21: $34.5M $34.5M FY21FY22: $35.4M $35.4M FY22FY23: $42.2M $42.2M FY23FY24: $53.5M $53.5M FY24FY25: $58.4M $58.4M FY25
Net income
FY20: -$14.7M -$14.7M FY20FY20: -$19.8M -$19.8M FY20FY21: -$19.6M -$19.6M FY21FY22: -$19.9M -$19.9M FY22FY23: -$14.4M -$14.4M FY23FY24: -$31.4M -$31.4M FY24FY25: -$34.3M -$34.3M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$58.4M-$24.6M-$34.3M-$2.87-$14.9M
2024$53.5M-$10.7M-$31.4M-$2.73-$2.4M
2023$42.2M-$12.2M-$14.4M-$1.31-$9.9M
2022$35.4M-$20.2M-$19.9M-$1.96-$15M
2021$34.5M-$19.7M-$19.6M-$2.09-$9.3M
2020$26.4M-$18.5M-$19.8M-$4.28-$14.2M

Latest SEC filings

What LENSAR, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. August 13, 2026
    Quarterly report 10-Q · period to June 30, 2026
  2. August 13, 2026
  3. August 10, 2026
  4. July 29, 2026
  5. June 23, 2026
  6. June 23, 2026
  7. June 23, 2026
  8. June 2, 2026
  9. May 29, 2026
  10. May 14, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on June 5, 2026. Insider transactions on SEC

All filings on SEC EDGAR

Questions about LNSR

What does LENSAR, Inc. do?

LENSAR, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker LNSR.

Is LENSAR, Inc. profitable?

Yes. Over the twelve months to June 30, 2026 it reported net income of $34.7M on revenue of $60.3M, a net margin of 57.6%.

How much revenue does LENSAR, Inc. make?

Over the twelve months to June 30, 2026 LENSAR, Inc. reported revenue of $60.3M. That is 3.3% more than a year earlier.

When did LENSAR, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026.

Similar companies

Follow LNSR

Get an email when LENSAR, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow LNSR: get an email when it files

Where the numbers come from

Financial figures are the values LENSAR, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.